Yale School of Medicine - Obstetrics, Gynecology & Reproductive Sciences | Strategic Alliance Partners

Sangini Sheth, MD, MPH, highlights that the updated HRSA guidelines empower patients by offering FDA-approved self-collection options for primary HPV testing.

Yale's Alessandro Santin, MD, emphasizes that "knowing our enemy" through sequencing is a way to identify targetable pathways for rare and aggressive ESS cases.

Alessandro Santin, MD, highlights how POLE and mismatch repair mutations in high-grade ESS create a clinical opportunity for using immune checkpoint inhibitors.

"It's only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets," said study investigator Alessandro Santin, MD.

In a new study, Yale researchers show that the placenta regulates serotonin delivery to the fetus, contrary to past beliefs that it manufactures the hormone.

Many individuals living with chronic diseases today still have few effective treatment options. In the future, Bobcat339 or its derivatives could be a new tool for helping patients manage their conditions.

A new study finds IVF can be successful even in people with thin endometria, challenging previously held beliefs by fertility specialists.

A new Yale study suggests women with high blood pressure before and during pregnancy may benefit from targeted interventions to support breastfeeding.

Many of the symptoms of endometriosis, including pain and infertility, are likely caused by inflammation. A new study identifies a potential treatment.